Connect Biopharma | 20-F: Registration statement / Annual report / Transition report
Connect Biopharma | 6-K: Report of foreign private issuer (related to financial reporting)
Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Panacea Innovation Limited(21.8%),Panacea Venture Healthcare Fund II, L.P.(21.8%), etc.
Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.
Connect Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Panacea Innovation Limited(16.2%),Panacea Venture Healthcare Fund II, L.P.(16.2%), etc.
Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wubin Pan(12.1%),BioFortune Inc(11.2%)
Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Zheng Wei(11.7%)
Connect Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(5.6%),Peter Kolchinsky(5.6%), etc.
Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.3%),Peter Kolchinsky(9.3%), etc.
Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Connect Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(10.8%),Peter Kolchinsky(10.8%), etc.
Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data